Invesco
PETX

Invesco’s Aratana Therapeutics, Inc. PETX Stock Holding History

Invesco’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-160,933
Closed -$1.16M – 3785
2016
Q4 		$1.16M Buy
+160,933
New +$1.3M ﹤0.01% 2917
2015
Q3 		– Sell
-392
Closed -$6K – 4134
2015
Q2 		$6K Buy
+392
New +$5.66K ﹤0.01% 4158

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco's PETX Position: Q1 2017 in Review

Invesco sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2017, closing a stake of 160,933 shares — an estimated $1.16M sold.

Invesco first reported a position in PETX in Q2 2015 and held it in 2 quarters. The position peaked at $1.16M in Q4 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

  • Invesco reported no remaining Aratana Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Invesco sold 160,933 Aratana Therapeutics, Inc. shares in Q1 2017, an estimated $1.16M.
  • Invesco first reported a position in Aratana Therapeutics, Inc. in Q2 2015 and held it in 2 quarters.
  • Invesco's Aratana Therapeutics, Inc. position peaked at $1.16M in Q4 2016.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.